SCHEMBL16076233

SCHEMBL16076233

CCCCn1c(=O)c2c(nc(SC)n2Cc2ccc(Cl)cc2)n(C)c1=O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 5/20 0.63
▸ ATM Q13315 2/20 0.60
▸ APOBEC3G Q9HC16 1/20 0.60
▸ MAPT P10636 4/20 0.59
▸ ALDH1A1 P00352 4/20 0.59
▸ NPSR1 Q6W5P4 3/20 0.59
▸ MAPK1 P28482 1/20 0.59
▸ HTT P42858 1/20 0.56
▸ LMNA P02545 3/20 0.53
▸ SMN1; SMN2 Q16637 1/20 0.53
▸ MAOA P21397 3/20 0.52
▸ MAOB P27338 3/20 0.52
▸ RAB9A P51151 1/20 0.52
▸ TP53 P04637 2/20 0.52
▸ MEN1 O00255 1/20 0.52
▸ USP2 O75604 1/20 0.52
▸ HPGD P15428 1/20 0.52
▸ KMT2A Q03164 1/20 0.52
▸ HSD17B10 Q99714 1/20 0.52
▸ KCNH2 Q12809 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16076235 0.90 TSHR (0.78) TSHRMAPTALDH1A1NPSR1MAPK1
SCHEMBL19505522 0.90 TRPC5 (0.62) TSHRATMAPOBEC3GMAPTALDH1A1
SCHEMBL16076237 0.89 ALDH1A1 (0.77) TSHRATMAPOBEC3GMAPTALDH1A1
SCHEMBL19505260 0.85 TSHR (0.53) TSHRATMAPOBEC3GMAPTALDH1A1
SCHEMBL16076164 0.84 MAPT (0.61) TSHRATMMAPTALDH1A1NPSR1
SCHEMBL16076179 0.84 MAPT (0.61) TSHRATMMAPTALDH1A1NPSR1
SCHEMBL16076165 0.84 TSHR (0.68) TSHRATMMAPTALDH1A1NPSR1
SCHEMBL18834862 0.84 BRAF (0.63) TSHRMAPTALDH1A1NPSR1MAPK1
SCHEMBL19375018 0.83 ALDH1A1 (0.64) TSHRMAPTALDH1A1NPSR1MAPK1
SCHEMBL16076222 0.80 TRPC5 (0.60) TSHRATMMAPTALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9969736-B2 Substituted xanthines and methods of use thereof HYDRA BIOSCIENCES, INC. (US) 2018-05-15 — — US disclosed
US-20170305910-A1 Substituted Xanthines and Methods of Use Thereof BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2017-10-26 — — US disclosed
US-20160237089-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF HYDRA BIOSCIENCES, INC. 2016-08-18 — — US disclosed
US-20140275071-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF HYDRA BIOSCIENCES, INC. (US) 2014-09-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170305910-A1 Substituted Xanthines and Methods of Use Thereof TRPC5, TRPC7, TRPC4 TSHR 4540/4885ATM 4310/4885APOBEC3G 2111/4885
US-20140275071-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF TRPC5, TRPC7, TRPC4 TSHR 4540/4885ATM 4310/4885APOBEC3G 2111/4885
US-20160237089-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF TRPC5, TRPC7, TRPC4 TSHR 4540/4885ATM 4310/4885APOBEC3G 2111/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback